{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:25:30Z","timestamp":1769271930358,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007278","name":"Henry Ford Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-018560"],"award-info":[{"award-number":["INV-018560"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ijid.2021.12.343","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T01:27:07Z","timestamp":1640222827000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3916-4021","authenticated-orcid":false,"given":"John E.","family":"McKinnon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dee Dee","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Zervos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-6442","authenticated-orcid":false,"given":"Matt","family":"Saval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Marshall-Nightengale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kilgore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pardeep","family":"Pabla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Szandzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8839-9906","authenticated-orcid":false,"given":"Kathleen","family":"Maksimowicz-McKinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William W.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June","key":"10.1016\/j.ijid.2021.12.343_bib0001","article-title":"Hydroxychloroquine for SARS CoV2 Prophylaxis in Healthcare Workers \u2013 A Multicentric Cohort Study Assessing Effectiveness and Safety","volume":"69","author":"Dinesh","year":"2021","journal-title":"Journal of The Association of Physicians of India"},{"issue":"7","key":"10.1016\/j.ijid.2021.12.343_bib0002","doi-asserted-by":"crossref","first-page":"ofab254","DOI":"10.1093\/ofid\/ofab254","article-title":"Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"8","author":"Bariola","year":"2021","journal-title":"Open forum infectious diseases"},{"issue":"35","key":"10.1016\/j.ijid.2021.12.343_bib0003","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.15585\/mmwr.mm7035e5","article-title":"Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021","volume":"70","author":"Boehmer","year":"2021","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"6","key":"10.1016\/j.ijid.2021.12.343_bib0004","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"The New England journal of medicine"},{"issue":"5","key":"10.1016\/j.ijid.2021.12.343_bib0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/trstmh\/trab047","article-title":"Risk factors and frequency of COVID-19 among healthcare workers at a tertiary care centre in India: a case-control study","volume":"115","author":"Dev","year":"2021","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1016\/j.ijid.2021.12.343_bib0006","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/joa3.12578","article-title":"COVID-19 induced bradyarrhythmia and relative bradycardia: An overview","volume":"37","author":"Douedi","year":"2021","journal-title":"Journal of arrhythmia"},{"issue":"2","key":"10.1016\/j.ijid.2021.12.343_bib0007","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2991\/jegh.k.200402.001","article-title":"Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care","volume":"10","author":"Dronavalli","year":"2020","journal-title":"Journal of epidemiology and global health"},{"key":"10.1016\/j.ijid.2021.12.343_bib0008","unstructured":"Food and Drug Administration. Food and Drug Administration (FDA) revoke the Emergency Use Autorization (EUA) for emergency use of oral formulations of chloroquine phosphate (CQ) and hydroxychloroquine sulfate (HCQ). https:\/\/www.fda.gov\/media\/138945\/download 2020."},{"key":"10.1016\/j.ijid.2021.12.343_bib0009","doi-asserted-by":"crossref","unstructured":"Fram G, Wang DD, Malette K, Villablanca P, Kang G, So K, et\u00a0al. Cardiac Complications Attributed to Hydroxychloroquine: A systematic review of the Literature Pre-COVID-19. Submitted 2020.","DOI":"10.2174\/1573403X16666201014144022"},{"issue":"5","key":"10.1016\/j.ijid.2021.12.343_bib0010","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/jac\/dkr089","article-title":"Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study","volume":"66","author":"Hiba","year":"2011","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"10223","key":"10.1016\/j.ijid.2021.12.343_bib0011","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijid.2021.12.343_bib0012","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/0022-1317-4-2-203","article-title":"Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs","author":"Inglot","year":"1969","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.ijid.2021.12.343_bib0013","unstructured":"Johns Hopkins University of Medicine. Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/data\/mortality; 2021. [Accessed August 20 2021]."},{"issue":"1","key":"10.1016\/j.ijid.2021.12.343_bib0014","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.ijid.2021.12.343_bib0015","article-title":"Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis","author":"Ladapo","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ijid.2021.12.343_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ijid.2021.12.343_bib0017","article-title":"Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19","author":"Lofgren","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ijid.2021.12.343_bib0018","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","author":"Magagnoli","year":"2020","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.ijid.2021.12.343_bib0019","doi-asserted-by":"crossref","first-page":"517","DOI":"10.31083\/j.rcm.2020.04.264","article-title":"Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)","volume":"21","author":"McCullough","year":"2020","journal-title":"Reviews in cardiovascular medicine"},{"key":"10.1016\/j.ijid.2021.12.343_bib0020","article-title":"Retraction\u2014Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis","author":"Mehra","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.ijid.2021.12.343_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100709","article-title":"Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world","author":"Million","year":"2020","journal-title":"New Microbes and New Infections"},{"issue":"5","key":"10.1016\/j.ijid.2021.12.343_bib0022","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa2021801","article-title":"A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19","volume":"384","author":"Mitj\u00e0","year":"2021","journal-title":"The New England journal of medicine"},{"issue":"6","key":"10.1016\/j.ijid.2021.12.343_bib0023","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.4103\/jfmpc.jfmpc_2338_20","article-title":"Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19","volume":"10","author":"Mittal","year":"2021","journal-title":"Journal of family medicine and primary care"},{"key":"10.1016\/j.ijid.2021.12.343_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.605185","article-title":"Hydroxychloroquine as Prophylaxis for COVID-19: A Review","volume":"11","author":"Monti","year":"2020","journal-title":"Frontiers in pharmacology"},{"issue":"1","key":"10.1016\/j.ijid.2021.12.343_bib0025","first-page":"76","article-title":"Diaa El-Deen AM. Contemporary approach to understand and manage COVID-19-related arrhythmia. The Egyptian heart journal: (EHJ): official bulletin of the Egyptian Society of","volume":"73","author":"Nabeh","year":"2021","journal-title":"Cardiology"},{"key":"10.1016\/j.ijid.2021.12.343_bib0026","article-title":"Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study","author":"Nguyen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ijid.2021.12.343_bib0027","unstructured":"Observational Health Data Sciences and Informatics (OHDSI). Oxford-led international research finds hydroxychloroquine safe in over 130,000 patients. https:\/\/sundiatapost.com\/oxford-led-international-research-finds-hydroxychloroquine-safe-in-over-130000-patients\/ 2020."},{"key":"10.1016\/j.ijid.2021.12.343_bib0028","first-page":"1","article-title":"Covid-19 and development of heart failure: mystery and truth","author":"Onohuean","year":"2021","journal-title":"Naunyn-Schmiedeberg's archives of pharmacology"},{"key":"10.1016\/j.ijid.2021.12.343_bib0029","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants","author":"Pegu","year":"2021","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.ijid.2021.12.343_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102468","article-title":"The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19","volume":"111","author":"Perricone","year":"2020","journal-title":"Journal of Autoimmunity"},{"issue":"11","key":"10.1016\/j.ijid.2021.12.343_bib0031","doi-asserted-by":"crossref","first-page":"e835","DOI":"10.1093\/cid\/ciaa1571","article-title":"Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial","volume":"72","author":"Rajasingham","year":"2021","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.ijid.2021.12.343_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100758","article-title":"Lancet gate: a matter of fact or a matter of concern","volume":"38","author":"Raoult","year":"2020","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.ijid.2021.12.343_bib0033","article-title":"Hydroxychloroquine For Prophylaxis Of COVID-19 In Health Workers: A Randomized Clinical Trial","author":"Rojas-Serrano","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.ijid.2021.12.343_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.8630","article-title":"Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State","author":"Rosenberg","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.ijid.2021.12.343_bib0035","first-page":"314","article-title":"Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial","volume":"106","author":"Seet","year":"2021","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"1","key":"10.1016\/j.ijid.2021.12.343_bib0036","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12985-021-01633-w","article-title":"Evolutionary trajectory of SARS-CoV-2 and emerging variants","volume":"18","author":"Singh","year":"2021","journal-title":"Virology journal"},{"key":"10.1016\/j.ijid.2021.12.343_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/postgradmedj-2020-137785","article-title":"Hydroxychloroquine and covid-19","author":"Sinha","year":"2020","journal-title":"Postgraduate Medical Journal"},{"issue":"8","key":"10.1016\/j.ijid.2021.12.343_bib0038","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/M20-4207","article-title":"Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial","volume":"173","author":"Skipper","year":"2020","journal-title":"Annals of internal medicine"},{"issue":"6","key":"10.1016\/j.ijid.2021.12.343_bib0039","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nature reviews Immunology"},{"key":"10.1016\/j.ijid.2021.12.343_bib0040","series-title":"Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States","author":"Tenforde","year":"2021"},{"key":"10.1016\/j.ijid.2021.12.343_bib0041","first-page":"1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","author":"Tregoning","year":"2021","journal-title":"Nature reviews Immunology"},{"key":"10.1016\/j.ijid.2021.12.343_bib0042","unstructured":"US Department of Health & Human Services. https:\/\/healthdata.gov\/Community\/COVID-19-State-Profile-Report-Michigan\/s8hn-gz3c; 2021. [Accessed August 13, 2021."},{"issue":"6","key":"10.1016\/j.ijid.2021.12.343_bib0043","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/JOM.0000000000002174","article-title":"Association Between Implementation of a Universal Face Mask Policy for Healthcare Workers in a Health Care System and SARS-CoV-2 Positivity Testing Rate in Healthcare Workers","volume":"63","author":"Wang","year":"2021","journal-title":"J Occup Environ Med"},{"issue":"3","key":"10.1016\/j.ijid.2021.12.343_bib0044","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jir.2014.0038","article-title":"Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery","volume":"35","author":"Wang","year":"2015","journal-title":"Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research"},{"issue":"3","key":"10.1016\/j.ijid.2021.12.343_bib0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ijid.2021.12.343_bib0046","unstructured":"World Health Organization. WHO Living guideline: Drugs to prevent COVID-19; 2021. [Accessed December 14 2021]."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221012431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221012431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:06:55Z","timestamp":1761120415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221012431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"alternative-id":["S1201971221012431"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.12.343","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.12.343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}